AMPHISTA THERAPEUTICS
Amphista Therapeutics operates as a biopharmaceutical company creating first-in-class cancer therapeutics that harness the body's natural processes to selectively and efficiently degrade and remove disease causing proteins.
AMPHISTA THERAPEUTICS
Social Links:
Industry:
Biopharma Biotechnology
Founded:
2017-01-01
Address:
Motherwell, North Lanarkshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.amphista.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
60.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Mobile Non Scaleable Content
Similar Organizations
Accent Therapeutics
Accent Therapeutics is a biopharmaceutical company.
Arkuda Therapeutics
Arkuda Therapeutics is a pharmaceutical company.
Highlight Therapeutics
Highlight Therapeutics is a clinical-stage biopharmaceutical company.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Leap Therapeutics
Leap Therapeutics is a clinical-stage biopharmaceutical company.
Neumora Therapeutics
Neumora Therapeutics operates as a clinical-stage biotechnology company.
Ocugen
Ocugen is a clinical stage biopharmaceutical company.
ORIC Pharmaceuticals
ORIC Pharmaceuticals operates as a biopharmaceutical company.
ppm.Ingredients
ppm.Ingredients operates as a biopharmaceutical company.
Werewolf Therapeutics
Werewolf Therapeutics operates as an oncology biotherapeutics company.
Current Advisors List
Current Employees Featured
Founder
Investors List
Forbion Capital Partners
Forbion Capital Partners investment in Series B - Amphista Therapeutics
Advent Life Sciences
Advent Life Sciences investment in Series B - Amphista Therapeutics
Gilde Healthcare
Gilde Healthcare investment in Series B - Amphista Therapeutics
Novartis Venture Fund
Novartis Venture Fund investment in Series B - Amphista Therapeutics
BioMotiv
BioMotiv investment in Series B - Amphista Therapeutics
Eli Lilly & Company Foundation
Eli Lilly & Company Foundation investment in Series B - Amphista Therapeutics
BioMotiv
BioMotiv investment in Series A - Amphista Therapeutics
European Investment Fund
European Investment Fund investment in Series A - Amphista Therapeutics
Scottish Investment Bank
Scottish Investment Bank investment in Series A - Amphista Therapeutics
Advent Life Sciences
Advent Life Sciences investment in Series A - Amphista Therapeutics
Key Employee Changes
Date | New article |
---|---|
2021-12-06 | Amphista Therapeutics Appoints Dr Martin Pass as CDO |
2021-09-21 | Amphista Therapeutics Appoints New Chairman, Joshua T. Brumm |
2020-05-21 | Amphista Therapeutics Appoints Leading Protein Degradation Pioneer, Ian Churcher as CSO |
Official Site Inspections
http://www.amphista.com
- Host name: 77.68.6.111
- IP address: 77.68.6.111
- Location: United Kingdom
- Latitude: 51.4964
- Longitude: -0.1224
- Timezone: Europe/London